Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Rubius Therapeutics Inc (RUBY)

Rubius Therapeutics Inc (RUBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Rubius Therapeutics, Inc. is a bio-technology company. It develops cellular therapies for the treatment of auto-immune, metabolic and other diseases. Rubius Therapeutics, Inc. is based in Cambridge, United States.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Dec, 2022 Sep, 2022 Jun, 2022 Mar, 2022 Dec, 2021
Sales 0 0 0 0 0
Sales Growth unch unch unch unch unch
Net Income -20,140 -62,870 -44,240 -52,410 -55,020
Net Income Growth +67.97% -42.11% +15.59% +4.74% -12.24%

Balance Sheet

(Values in U.S. Thousands) Dec, 2022 Sep, 2022 Jun, 2022 Mar, 2022 Dec, 2021
Total Assets 23,070 170,700 229,080 267,120 318,020
Total Assets Growth -86.49% -25.48% -14.24% -16.01% -11.92%
Total Liabilities 7,940 134,110 133,540 132,470 139,240
Total Liabilities Growth -94.08% +0.43% +0.81% -4.86% +1.74%

Cash Flow

(Values in U.S. Thousands) Dec, 2022 Sep, 2022 Jun, 2022 Mar, 2022 Dec, 2021
Operating Cash Flow -150,140 -117,630 -81,420 -47,140 -145,120
Operating Cash Flow Growth -27.64% -44.47% -72.72% +67.52% -34.48%
Net Cash Flow -212,670 -122,130 -163,800 -127,910 134,680
Change in Net Cash Flow -74.13% +25.44% -28.06% -194.97% -22.08%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.